Taurine attenuates amyloid β 1-42-induced mitochondrial dysfunction by activating of SIRT1 in SK-N-SH cells

Biochemical and Biophysical Research Communications

Volumn 447, Issue 3, 2014, Pages 485-489

  Sun, Qinru ^a   Hu, Haitao ^a   Wang, Weixi ^a   Jin, Hui ^a   Feng, Gaifeng ^a   Jia, Ning ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Amyloid ; Calcium; Mitochondrial permeability transition pore; Reactive oxygen species; Sirtuin 1; Taurine

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; CALCIUM ION; REACTIVE OXYGEN METABOLITE; SIRTUIN 1; TAURINE;

ALZHEIMER DISEASE; ARTICLE; CALCIUM CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; PRIORITY JOURNAL;

AMYLOID Β; CALCIUM; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN SPECIES; SIRTUIN 1; TAURINE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CALCIUM; CELL LINE, TUMOR; HUMANS; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIRTUIN 1; TAURINE;

EID: 84900333986     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.04.019     Document Type: Article

References (28)

1. Drachman D.A. Aging of the brain, entropy, and Alzheimer disease. Neurology 2006, 67:1340-1352.
2. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N.Y. Acad. Sci. 2000, 924:17-25.
3. Chen J.X., Yan S.S. Role of mitochondrial amyloid-beta in Alzheimer's disease. J. Alzheimers Dis. 2010, 20(Suppl. 2):S569-S578.
4. Du H., Yan S.S. Mitochondrial medicine for neurodegenerative diseases. Int. J. Biochem. Cell Biol. 2010, 42:560-572.
5. Khan R.S., Dine K., Das Sarma J., Shindler K.S. SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease. Acta Neuropathol. Commun. 2014, 2:3.
6. Khan R.S., Fonseca-Kelly Z., Callinan C., Zuo L., Sachdeva M.M., Shindler K.S. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells. Front. Cell. Neurosci. 2012, 6:63.
7. Lalla R., Donmez G. The role of sirtuins in Alzheimer's disease. Front. Aging Neurosci. 2013, 5:16.
8. Jayasena T., Poljak A., Smythe G., Braidy N., Munch G., Sachdev P. The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease. Ageing Res. Rev. 2013, 12:867-883.
9. Hammes T.O., Pedroso G.L., Hartmann C.R., Escobar T.D., Fracasso L.B., da Rosa D.P., Marroni N.P., Porawski M., da Silveira T.R. The effect of taurine on hepatic steatosis induced by thioacetamide in zebrafish (Danio rerio). Dig. Dis. Sci. 2012, 57:675-682.
10. Chou C.T., Lin W.F., Kong Z.L., Chen S.Y., Hwang D.F. Taurine prevented cell cycle arrest and restored neurotrophic gene expression in arsenite-treated SH-SY5Y cells. Amino Acids 2013, 45:811-819.
11. Jong C.J., Azuma J., Schaffer S. Mechanism underlying the antioxidant activity of taurine: prevention of mitochondrial oxidant production. Amino Acids 2012, 42:2223-2232.
12. Kumari N., Prentice H., Wu J.Y. Taurine and its neuroprotective role. Adv. Exp. Med. Biol. 2013, 775:19-27.
13. Louzada P.R., Paula Lima A.C., Mendonca-Silva D.L., Noel F., De Mello F.G., Ferreira S.T. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders. FASEB J. 2004, 18:511-518.
14. Javed H., Khan A., Vaibhav K., Moshahid Khan M., Ahmad A., Ejaz Ahmad M., Tabassum R., Islam F., Safhi M.M. Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer's type (SDAT) caused by intracerebroventricular streptozotocin in rats. Neurol. Sci. 2013, 34:2181-2192.
15. Paula-Lima A.C., De Felice F.G., Brito-Moreira J., Ferreira S.T. Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons. Neuropharmacology 2005, 49:1140-1148.
16. Stine W.B., Dahlgren K.N., Krafft G.A., LaDu M.J. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 2003, 278:11612-11622.
17. Gharibani P.M., Modi J., Pan C., Menzie J., Ma Z., Chen P.C., Tao R., Prentice H., Wu J.Y. The mechanism of taurine protection against endoplasmic reticulum stress in an animal stroke model of cerebral artery occlusion and stroke-related conditions in primary neuronal cell culture. Adv. Exp. Med. Biol. 2013, 776:241-258.
18. Ferreira I.L., Resende R., Ferreiro E., Rego A.C., Pereira C.F. Multiple defects in energy metabolism in Alzheimer's disease. Curr. Drug Targets 2010, 11:1193-1206.
19. Muller M., Cheung K.H., Foskett J.K. Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling. Antioxid. Redox Signal. 2011, 14:1225-1235.
20. Sinha M., Manna P., Sil P.C. Taurine, a conditionally essential amino acid, ameliorates arsenic-induced cytotoxicity in murine hepatocytes. Toxicol. In Vitro 2007, 21:1419-1428.
21. Yang Y., Zhang Y., Liu X., Zuo J., Wang K., Liu W., Ge J. Exogenous taurine attenuates mitochondrial oxidative stress and endoplasmic reticulum stress in rat cardiomyocytes. Acta Biochim. Biophys. Sin. (Shanghai) 2013, 45:359-367.
22. Du H., Yan S.S. Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta. Biochim. Biophys. Acta 1802, 2010:198-204.
23. Chen K., Zhang Q., Wang J., Liu F., Mi M., Xu H., Chen F., Zeng K. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction. Brain Res. 2009, 1279:131-138.
24. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem. Soc. Trans. 2006, 34:232-237.
25. El Idrissi A. Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 2008, 34:321-328.
26. Ye H.B., Shi H.B., Yin S.K. Mechanisms underlying taurine protection against glutamate-induced neurotoxicity. Can. J. Neurol. Sci. 2013, 40:628-634.
27. Bonda D.J., Lee H.G., Camins A., Pallas M., Casadesus G., Smith M.A., Zhu X. The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations. Lancet Neurol. 2011, 10:275-279.
28. Braidy N., Jayasena T., Poljak A., Sachdev P.S. Sirtuins in cognitive ageing and Alzheimer's disease. Curr. Opin. Psychiatry 2012, 25:226-230.